Natasha C Moningka
Overview
Explore the profile of Natasha C Moningka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stabley J, Moningka N, Behnke B, Delp M
Med Sci Sports Exerc
. 2014 Mar;
46(11):2107-12.
PMID: 24658222
Introduction: The principal nutrient artery to the femur demonstrates an increase in nitric oxide-mediated vasodilation in rats after treadmill exercise training. The present study sought to determine whether exercise training...
2.
Moningka N, Cunningham Jr M, Sterling M, West C, Verlander J, Croker B, et al.
J Physiol
. 2012 Dec;
591(5):1313-24.
PMID: 23266936
Exercise-induced vascular endothelial adaptations in the kidney are not well understood. Therefore, we investigated the impact of voluntary wheel running (VWR) on the abundance of endothelial nitric oxide synthase (eNOS)...
3.
Sasser J, Akinsiku O, Moningka N, Jerzewski K, Baylis C, LeBlanc A, et al.
Gend Med
. 2012 Jul;
9(4):219-31.
PMID: 22819558
Background: Aging kidneys exhibit slowly developing injury and women are usually protected compared with men, in association with maintained renal nitric oxide. Objectives: Our purpose was to test 2 hypotheses:...
4.
Sasser J, Moningka N, Tsarova T, Baylis C
Life Sci
. 2012 Jun;
91(1-2):54-63.
PMID: 22727796
Aims: Nitric oxide (NO) deficiency contributes to chronic kidney disease progression. Nebivolol, a beta adrenergic receptor antagonist, may enhance endogenous NO. Here, we investigated whether Nebivolol attenuates hypertension and renal...
5.
Chen G, Moningka N, Sasser J, Zharikov S, Cunningham Jr M, Tain Y, et al.
Am J Nephrol
. 2011 Dec;
35(1):40-8.
PMID: 22179117
Background/aims: Reduced renal L-arginine (L-Arg) synthesis/transport, induction of arginases and increased endogenous NOS inhibitor, asymmetric dimethylarginine (ADMA) will inhibit NO production. This study investigated pathways of L-Arg synthesis/uptake/utilization, ADMA degradation...
6.
Moningka N, Sindler A, Muller-Delp J, Baylis C
J Physiol
. 2011 Oct;
589(Pt 24):6129-38.
PMID: 21969451
The ageing kidney exhibits slowly developing chronic kidney disease (CKD) and is associated with nitric oxide (NO) deficiency and increased oxidative stress. The impact of exercise on the ageing kidney...
7.
Moningka N, Tsarova T, Sasser J, Baylis C
Nephrol Dial Transplant
. 2011 Aug;
27(3):913-20.
PMID: 21856762
Background: Nitric oxide (NO) deficiency contributes to chronic kidney disease (CKD) progression and hypertension. The β-blocker, nebivolol (N), also enhances NO production, and we studied whether N attenuates CKD and...
8.
Moningka N, Sasser J, Croker B, Carter C, Baylis C
Mech Ageing Dev
. 2010 Nov;
132(1-2):1-7.
PMID: 21087620
Age-dependent renal damage is influenced by genetic background and the Fisher344xBrown Norway (F344xBN) rat is resistant to glomerular injury. In vulnerable strains, a fall in renal nitric oxide synthase (NOS)...
9.
Chen G, Wagner L, Sasser J, Zharikov S, Moningka N, Baylis C
Nephrol Dial Transplant
. 2010 May;
25(11):3518-25.
PMID: 20484304
Background: The fawn-hooded hypertensive (FHH) rat develops spontaneous glomerulosclerosis that is ameliorated by inhibition of the angiotensin II type 1 receptor (AT-1). Since kidney damage is associated with nitric oxide...
10.
Sasser J, Moningka N, Cunningham Jr M, Croker B, Baylis C
Am J Physiol Regul Integr Comp Physiol
. 2009 Dec;
298(3):R740-6.
PMID: 20018820
Recent studies have shown that asymmetric dimethylarginine (ADMA), a nitric oxide synthase inhibitor, is increased in hypertension and chronic kidney disease. However, little is known about the effects of hypertension...